chemotherapy hairloss

Come here to find hair loss treatments. A University developed treatment to help reverse hair loss. Click here

Though humans no longer make use of hair for protection, heat retention, or camouflage, it still remains a chemotherapy very important means by which individuals display and are recognized. Appropriate appearance and grooming are still very important in social hairloss organization and the human relationships.The human body contains approximately five million hair follicles while the scalp (prior to any kind of hair loss) contains 100,000 - 150,000 hair follicles. Blondes have the greatest number of scalp follicles, followed by brunettes. Humans with red hair have the fewest number of scalp follicles. The normal growth rate of scalp hair is one-fourth to one-half inch per month.

In summary, male chemotherapy pattern hair loss (Androgenetic Alopecia) is an inherited condition manifested when androgens are present in normal amounts. The gene can be inherited from the mother or father’s side. The onset, rate, and severity of hair loss are unpredictable. The severity increases with age and if the condition is hairloss present it will be progressive and relentless.FEMALE PATTERN HAIR LOSS (Androgenetic Alopecia)Female pattern hair loss (FPHL) differs from male pattern hair loss (MPHL) in the following ways. It is more likely to be noticed later than in men, in the late twenties through early forties. chemotherapy It is likely to be seen at times of hormonal hairloss change, i.e., use of birth control pills, after childbirth, chemotherapy around the time of menopause, and after menopause. Recession at the temples is less likely than in men and women tend to maintain the position of their hairlines. Like in men, the hairloss entire top of the scalp is the chemotherapy area of risk. In hairloss women there is generally chemotherapy a diffuse thinning throughout the area as opposed to thinning in the crown of men. hairloss and chemotherapy Ludwig has classified hairloss hair loss in women into three classes. (See Ludwig Classification) chemotherapy The vast majority of women affected fall into the Ludwig hairloss I class.

Hamilton first noted that androgens (testosterone, dihydrotestosterone) are necessary for the development of MPHL. The amount of androgens present does not need to be greater than normal chemotherapy for MPHL to occur. If hairloss androgens are present in normal amounts and the gene for hair loss is present, male pattern hair loss will occur. Axillary (under arm) and pubic hair are dependent on testosterone for growth. Beard growth and male pattern hair loss are dependent on dihydrotestosterone (DHT). Testosterone is converted to DHT by the enzyme, 5a -reductase. Finasteride (Propecia) acts by blocking this enzyme and decreasing the amount of DHT. Receptors exist on cells that bind androgens. These receptors have the greatest affinity for DHT followed by testosterone, estrogen, and progesterone. After binding chemotherapy to the receptor, DHT goes into the cell and interacts with the nucleus of the cell altering the production of hairloss protein by the DNA in the nucleus of the cell. Ultimately growth of the hair follicle ceases.

Come here to find hair loss treatments. A University developed treatment to help reverse hair loss.

chemotherapy hairloss

child hair loss	cocoa butter for hairloss	cure for hairloss	dandruff and hairloss
dealing with hairloss	dexamethasone hairloss	dexamethasone spiro bcp hairloss

2003 hair-loss-treatments.net. All Rights Reserved.